Burning issues for distributors

Serge Lignot , head of structured products at Fortis Bank in Brussels, looks at some of the main issuing considerations for distributors in Belgium

The past two years or so have seen fierce competition in the Belgian structured products market, and product choice has been on the increase too. Clients used to consist of only OLO (Belgian Bunds) investors, plain vanilla bond investors or those willing to accept more risk by investing in funds. But competitive market conditions have forced banks to come up with issues that attract sales with lower costs. Issuing structured notes within a fund has also become more popular.

The following points provide an overview of the factors that distributors currently need to consider when issuing products in Belgium.

Issue type

Issuance in Belgium is relatively expensive because average volumes are low compared to costs. Local regulations are very tough and approval is usually required from the CBFA (Banking, Finance and Insurance commission), which is the supervisory body for the country's financial sector.

Three types of structured product can be issued: funds, notes and insurance products. Most are regulated by the CBFA, and a distinction must be made between private and public issues. As a rule of thumb, issues with denominations of more than e250,000 are considered as private offerings. One of three features defines a public issue: publicity, the use of non-professional intermediaries, or approaching more than 50 people. The need for regulatory approval and documentation costs makes them difficult to issue for sizes under e5 million.

The existing rules will change in July, when the European investment directive comes into effect with the aim of creating a European standard.

Cost

Funds are subject to obligatory annual checks by auditors and the CBFA and are therefore the most expensive method of offering structured products to retail clients. For private placements, on the other hand, the costs are negligible. The administration of pension funds has a cost structure close to those of funds.

Coupon payments

Regardless of issue type, all coupon payments (before maturity) in Belgium are submitted to a withholding tax of 15%. If a structure pays annual coupons it makes no sense to put them under more expensive fiscal set-ups than notes.

If no coupons are paid, the final customer will profit more from structures under funds or pension fund schemes, because no withholding tax is liable on the capital gains. For structures in between these two extremes, it is up to the client or consultant to choose the most appropriate scheme.

Capital guarantee

Investors must ensure they check whether or not a structure they like propose a capital guarantee, and if the guarantee exceeds 100%. If the structure has an above-par reimbursement, then maturity becomes the driving parameter. Withholding tax will not be due if the structure has a maturity of more than than eight years, so most Belgian capitalisation structures have maturities of between eight and 10 years.

Odd one out

As if to confuse everyone, reverse convertibles have always been the odd one out under Belgian law, which states that withholding tax is due for investment products with a capital guarantee. However, gains on speculative instruments (as stocks or options) are not taxed. Reverse convertible structures in Belgium have historically been put under the form of a note. Unfortunately, however, the reverse coupons are not exempt from withholding tax.

Contact the author on serge.lignot@fortisbank.com

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here